Delisting riskPopularity #4,857
Theriva Biologics (TOVX)
Develops stroma-degrading oncolytic viruses for difficult-to-treat solid tumors.
$0.2320
vs last close+0.00 (+0.52%)
Something off on this page? Send us feedback.
Next report
Nov 17, 26
in 55 days
EPS estimate
−$0.07
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$6.03−$1.55−$1.93−$0.45$1.85−$0.05−$0.07Pending
Estimate−$7.22−$4.19−$0.38−$0.38−$0.44−$0.05−$0.06−$0.07
Surprise+183.5%+63.0%−407.9%−18.4%+525.3%0.0%−27.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$154.0K————$300.0K—Pending
Estimate—————$300.0K——
Surprise—————0.0%——
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.06 | — | — |
| Sep 2027 | −$0.06 | — | — |
| Jun 2027 | −$0.06 | — | — |
| Mar 2027 | −$0.06 | — | — |
| Dec 2026 | −$0.06 | — | — |
| Nov 2026 | −$0.07 | — | — |
| Aug 2026 | −$0.06 | −$0.07 | −27.3% |
| May 2026 | −$0.05 | −$0.05 | 0.0% |
| Mar 2026 | −$0.44 | $1.85 | +525.3% |
| Nov 2025 | −$0.38 | −$0.45 | −18.4% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.06 | — | — | $300.0K | — | — | — |
| Sep 2027 | −$0.06 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.06 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.06 | — | — | $300.0K | — | — | — |
| Dec 2026 | −$0.06 | — | — | $300.0K | — | — | — |
| Nov 17, 2026 | −$0.07 | — | — | $0 | — | — | — |
| Aug 11, 2026 | −$0.06 | −$0.07 | −27.3% | — | — | — | −0.4% |
| May 5, 2026 | −$0.05 | −$0.05 | 0.0% | $300.0K | $300.0K | 0.0% | +0.1% |
| Mar 12, 2026 | −$0.44 | $1.85 | +525.3% | — | — | — | −3.2% |
| Nov 12, 2025 | −$0.38 | −$0.45 | −18.4% | — | — | — | +8.1% |
| Aug 11, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 24, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 7, 2024 | |||||||
| Mar 25, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 17, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 5, 2021 | |||||||
| Mar 4, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 5, 2020 | |||||||
| Feb 20, 2020 | |||||||
| Nov 4, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 8, 2019 | |||||||
| Feb 27, 2019 | |||||||
| Nov 8, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 8, 2018 | |||||||
| Feb 22, 2018 | |||||||
| Nov 1, 2017 | |||||||
| Aug 3, 2017 | |||||||
| May 4, 2017 | |||||||
| Mar 2, 2017 | |||||||
| Nov 1, 2016 | |||||||
| Aug 3, 2016 | |||||||
| May 5, 2016 | |||||||
| Mar 10, 2016 | |||||||
| Nov 5, 2015 | |||||||
| Aug 10, 2015 |